Buprenorphine in the treatment of opiate withdrawal syndrome

By Diamant K.   Fischer G.   Schneider C.   Pezawas L.   Lenzinger E.   Kasper S.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 393-393

Elsevier

Access to resources Recommend Favorite

A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal

By Rosen M.I.   McMahon T.J.   Woods S.W.   Pearsall H.R.   Kosten T.R.  

European Journal of Pharmacology, Vol. 307, Iss. 3, 1996-07 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Buprenorphine/naloxone: Urinary hesitancy, treated with bethanechol: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Tramadol versus Buprenorphine for the Treatment of Opiate Withdrawal: A Retrospective Cohort Control Study

By Tamaskar Ranjit   Parran Theodore V.   Heggi Abdul   Brateanu Andrei   Rabb Mary   Yu Jaehak  

Journal of Addictive Diseases, Vol. 22, Iss. 4, 2003-12 ,pp. : 5-12

Haworth Press

Access to resources Recommend Favorite

Buprenorphine/naloxone: Various toxicities following unintentional exposure in infants and children: 9 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1352, 2011-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite